Lucy Godley, MD, PhD, completed her medical degree at Northwestern University Feinberg School of Medicine and the University of California San Francisco School of Medicine. Following this, she completed an internship, residency, and fellowship at the University of Chicago, where she currently works as an Assistant Professor.
Dr Godley is a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), and the American Society of Hematology (ASH).
Speaking on the molecular basis for inherited predisposition to leukemia
Dr Godley’s research is centered around leukemias, lymphomas and multiple myeloma, as well as stem cell transplantation. She has an interest in the molecular basis for inherited predisposition to leukemia and is an active researcher in this field.
Dr Godley’s laboratory conducts research on DNA methylation/hydroxymethylation patterns in hematopoietic malignancies to aid the development of rational therapies for these cancers. She has also been the Principal Investigator of Phase II clinical trials aiming to determine the effectiveness of combinations of drugs for the treatment of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).